Biogen Inc

NASDAQ: BIIB
$157.90
-$0.11 (-0.1%)
Closing Price on November 22, 2024

BIIB Articles

The August 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas, 10 tied mostly to retailing of apparel and accessories, and six are tied to pharmaceuticals and biotech.
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Biogen shares rose after itreleased better than expected second-quarter financial results before the markets opened on Tuesday.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The June 28 short interest data has been compared with the previous report, and short interest in most...
President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the effort being blocked on free speech concerns.
The top analyst upgrades, downgrades and initiations on Friday included Aerojet Rocketdyne, Apple, Baidu, Biogen, Chesapeake Energy, Chipotle Mexican Grill, McDonald's, Nike, Procter & Gamble and...
The June 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most...
The May 15 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks increased.
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover...
The April 30 short interest data have been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alibaba, Anadarko Petroleum, Beyond Meat, Boeing, Ctrip.com, GW Pharmaceuticals, Roku, Texas Instruments and Veeco...